The Role of Beta-blockers: 2023 ESH Guidelines for Managing Arterial Hypertension

The Role of Beta-blockers: 2023 ESH Guidelines for Managing Arterial Hypertension

In June, the 2023 European Society of Hypertension (ESH) Hypertension guidelines were published. Overall, the new report closely resembles its predecessor published in 2018. The guidelines confirm the preferred use of renin–angiotensin system blockers, calcium channel blockers and Thiazide/Thiazide-like diuretics, and their various combinations, for blood pressure lowering treatment. Beta-blockers (BBs) are included among the major antihypertensive medications.

Modern Medicine – Issue 5 2023

Verified by ExactMetrics